The Joint Blog

NOVEMBER 21, 2022

Regardless of personal opinion on CBD, the market continues to flourish and expand. Indeed, only in the United States, it is projected to hit $16 billion by 2025. But what are the exact use cases of CBD, and why are people so in love with this product? One of the most widely recognized benefits of CBD consumption.

Consumption 52

Consumption CBD Research and Development Topical 52

Cannabis Law Report

MAY 28, 2021

The system efficiently delivers active ingredients such as THC and CBD in both topical and transdermal applications. Cannabinoids, the active ingredients of cannabis including CBD and THC, are proliferating in topical creams and ointments throughout the world. CBD-infused topicals are expected to reach $4.5

Medicine 64

Medicine Wellness and Beauty Research and Development Topical 64

Cannabis Law Report

SEPTEMBER 10, 2019

Series A in major European CBD gambit. British medical marijuana and CBD company Cannaray has just closed a £7.8 Cannabidiol, known as CBD, is a key chemical present in plants like cannabis and hemp. Don’t confuse CBD with THC! billion by the end of 2025, according to a report released by Grand View Research, Inc.

CBD 45

CBD Wellness and Beauty Banking Epilepsy 45

Otherside Farms

SEPTEMBER 13, 2021

cannabis industry is projected to reach $30 billion in market value annually by 2025. Offers Pain Relief. From mild pain like pinched nerves or menstrual cramping to more chronic pain, Indica strains can help provide pain relief. Strains with higher CBD work better for relaxation. Helps with Insomnia.

Indica 52

Indica Sativa Strains Chronic Pain 52

Cannabis Law Report

FEBRUARY 18, 2020

Researchers predict that the market will be valued at $7 billion by the year 2025. And according to a Nielsen analytical report , the US market of legal marijuana will reach $41 billion in revenue by 2025, meaning that New York will make up close to 17% of the market share. Non-medical CBD -high products that contain less than 0.3%

Marijuana 59

Marijuana Consumption Dispensary Vaping 59

Cannabis Law Report

SEPTEMBER 13, 2021

Commenting on the size and scope of the market for delaying aging, Dr. Chapman added, “There are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 1 according to a major investment bank. For more information, visit www.mymd.com.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Therapy 40

Cannabis Law Report

NOVEMBER 16, 2021

The market for treating aging disorders and extending healthy lifespan is expected to be at least $600 billion by 2025 1 according to a major investment bank. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. For more information, visit www.mymd.com.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

Veriheal

JUNE 19, 2025

A 2025 BBC report revealed that at least 382 families, identified through online forums and interviews conducted by the parent support charity MedCan, are sourcing cannabis medicines illegally—many to manage severe forms of epilepsy that conventional treatments have failed to control.

Patients 52

Patients Epilepsy Medicine Access 52

Otherside Farms

NOVEMBER 13, 2019

The CBD business is growing at an alarming rate and with good reason. In actuality, experts project that the industry will be worth sixteen billion dollars by the end of 2025. However, why is the dependency rate on CBD and related compounds increasing by the minute? Cannabidiol Alleviates Chronic Pain.

CBD 53

CBD Chronic Pain Blood Pressure Sleep 53

Cannabis Law Report

OCTOBER 20, 2019

For example, there is a growing body of evidence that marijuana is working for chronic pain. Whether or not the pharmaceutical industry can produce a substance they can call a drug that would be approved for a pain indication remains the question,” [xiv]. billion in federal tax revenue between 2017 and 2025. xv] [link].

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Cannabis Law Report

JANUARY 5, 2022

3 MyMD believes that there are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 according to a major investment bank. MyMD also holds three patents for its synthetic cannabidiol (CBD) derivative Supera-CBD.

Pharmaceutical 40

Pharmaceutical Clinical Trials Therapy Treatment 40

Cannabis Law Report

MAY 19, 2019

Cannabis plant or its resin or extract with THC content lower than 1% is considered as CBD (medical) cannabis and not psychoactive. billion dollars by 2025. A careful reading of the 1961 Single Convention on Narcotic Drugs reveal that Narcotics may be used by signatory states for research and medical purposes. Recommendations.

Legalization 45

Legalization Seed-To-Sale Marijuana Decriminalization 45

Cannabis Law Report

OCTOBER 17, 2019

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. Not only are makers of foods, health and beauty products, and supplements interested in CBD and THC.

Law 40

Law Seed-To-Sale Hemp Recreational 40